Mapp Biopharmaceutical also offered funding as sponsor on the IND for MB66, and performed a task inside the review structure, conclusion to publish and preparing of your manuscript. Scientists executed a Period 1 clinical trial to assess the safety, acceptability, drug distribution and usefulness